Literature DB >> 26765485

Significant hepatic expression of IL-2 and IL-8 in biliary atresia compared with other neonatal cholestatic disorders.

Reda Sanad Arafa1, Omima M Abdel Haie1, Dina Shehata El-Azab2, Amira Mohamed Abdel-Rahman1, Mostafa M Sira3.   

Abstract

OBJECTIVES: Although the exact etiology of biliary atresia (BA) is still elusive, inflammation plays a key role. Release of proinflammatory cytokines from activated immune cells perpetuates the injury and causes biliary destruction. We aimed to study interleukin (IL)-2 and IL-8 expression in liver tissue of BA patients compared with other neonatal cholestatic disorders.
METHODS: The study included 59 infants with neonatal cholestasis in two groups; BA group (n=31) and non-BA group (n=28) with cholestatic disorders other than BA as controls. Demographic, clinical, laboratory, and histopathological parameters were collected. IL-2 and IL-8 immunostaining was performed. Immunostaining in portal cellular infiltrate was scored as positive or negative and expressed as the mean cell count in three portal tracts.
RESULTS: The mean value of IL-2 and IL-8 positive inflammatory cells was significantly higher in BA than in non-BA group (P-values of 0.004 and 0.002 respectively). IL-2 correlated significantly with IL-8 immunostaining in both BA and non-BA group (P<0.0001 for both). Furthermore, both cytokines in both groups correlated significantly with inflammatory activity in liver biopsy while there was no significant correlation with the other studied parameters. Yet, there was a trend of increased expression of IL-2 and IL-8 with increasing stage of fibrosis in BA group. This trend was not observed in non-BA group.
CONCLUSION: The significantly higher expression of IL-2 and IL-8 in patients with BA compared to non-BA suggests a potential role for these cytokines in the pathogenesis in therapy of this devastating neonatal hepatic disorder.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biliary atresia; Etiopathogenesis; Immunostaining; Interleukin 2; Interleukin 8; Neonatal cholestasis

Mesh:

Substances:

Year:  2016        PMID: 26765485     DOI: 10.1016/j.cyto.2015.12.023

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  Diagnostic values of plasma matrix metalloproteinase-7, interleukin-8, and gamma-glutamyl transferase in biliary atresia.

Authors:  Bo Wu; Ying Zhou; Xinbei Tian; Wei Cai; Yongtao Xiao
Journal:  Eur J Pediatr       Date:  2022-09-12       Impact factor: 3.860

Review 2.  Biliary Atresia: A Complex Hepatobiliary Disease with Variable Gene Involvement, Diagnostic Procedures, and Prognosis.

Authors:  Consolato M Sergi; Susan Gilmour
Journal:  Diagnostics (Basel)       Date:  2022-01-27

3.  Preoperative Serum IL-12p40 Is a Potential Predictor of Kasai Portoenterostomy Outcome in Infants with Biliary Atresia.

Authors:  Shaimaa Samy Goda; Mohamed Ahmed Khedr; Soha Zaki Elshenawy; Tarek Mohamed Ibrahim; Hanaa Ahmed El-Araby; Mostafa Mohamed Sira
Journal:  Gastroenterol Res Pract       Date:  2017-05-15       Impact factor: 2.260

4.  Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin Therapy.

Authors:  Sehee Kim; Jeffrey Moore; Estella Alonso; Joseph Bednarek; Jorge A Bezerra; Catherine Goodhue; Saul J Karpen; Kathleen M Loomes; John C Magee; Vicky L Ng; Averell H Sherker; Caroline Smith; Cathie Spino; Veena Venkat; Kasper Wang; Ronald J Sokol; Cara L Mack
Journal:  Hepatol Commun       Date:  2019-03-25

5.  Immune Status in Children Before Liver Transplantation-A Cross-Sectional Analysis Within the ChilsSFree Multicentre Cohort Study.

Authors:  Tamara Möhring; André Karch; Christine S Falk; Tobias Laue; Lorenzo D'Antiga; Dominique Debray; Loreto Hierro; Deirdre Kelly; Valerie McLin; Patrick McKiernan; Joanna Pawlowska; Piotr Czubkowski; Rafael T Mikolajczyk; Ulrich Baumann; Imeke Goldschmidt
Journal:  Front Immunol       Date:  2019-01-25       Impact factor: 7.561

6.  Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis.

Authors:  Lin He; Dennis Kai Ming Ip; Greta Tam; Vincent Chi Hang Lui; Paul Kwong Hang Tam; Patrick Ho Yu Chung
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

7.  mRNA and lncRNA expression profiles of liver tissues in children with biliary atresia.

Authors:  Wenyan Wu; Weifang Wu; Yongqin Ye; Tao Li; Bin Wang
Journal:  Exp Ther Med       Date:  2022-08-22       Impact factor: 2.751

8.  Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent.

Authors:  Haimei Zhu; Yuji Wang; Ce Song; Qiqi Feng; Jianhui Wu; Shurui Zhao; Lin Gui; Xiaoyi Zhang; Ming Zhao; Shiqi Peng
Journal:  Oncotarget       Date:  2017-07-19

9.  Identification of Liver Immune Microenvironment-Related Hub Genes in Liver of Biliary Atresia.

Authors:  Jiaxu Zhang; Yi Luo; Mingxuan Feng; Qiang Xia
Journal:  Front Pediatr       Date:  2022-01-17       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.